The Australia intravenous solution market was valued at USD 407.60 Million in 2025 and is expected to grow at a CAGR of 6.40%, reaching USD 757.97 Million by 2035. The market growth is driven robust healthcare infrastructure, increased hospital admissions, and a growing aging population requiring fluid therapy. Advancements in parenteral nutrition and expanding use in post-surgical care support market value. The shift toward home-based IV treatments and improved distribution networks is expected to boost demand during the forecast period.
Base Year
Historical Period
Forecast Period
According to the Australian Institute of Health and Welfare 2025, over 15,770 deaths in 2022 were caused by infectious diseases, driving increased demand for intravenous solutions to support effective treatment and fluid management across healthcare settings.
Rising demand for advanced healthcare infrastructure, growing geriatric population, and increasing surgical procedures are key factors driving the market growth, boosting adoption across hospitals and specialty clinics.
Market growth in Australia is strongly supported by strategic initiatives, product innovations, and regional expansion efforts from key industry players, enhancing product accessibility and improving intravenous therapy standards nationwide.
Compound Annual Growth Rate
6.4%
Value in USD Million
2026-2035
*this image is indicative*
Intravenous (IV) solutions are an essential component in modern clinical care, widely used for fluid replacement, medication delivery, and electrolyte balance across emergency, surgical, and chronic care settings. The market is poised to grow at a CAGR of 6.40% during the forecast period of 2026–2035. It is experiencing consistent growth due to rising hospital admissions, an aging population, and increasing prevalence of chronic diseases. Furthermore, advancements in healthcare infrastructure and supportive government policies are enhancing product demand across both public and private sectors.
Rising Chronic Disease Burden to Drive the Growth in the Market
The increasing prevalence of chronic diseases remains a key driver of growth in the market. As reported by the Australian Institute of Health and Welfare in its Australian Burden of Disease Study 2024, five major disease groups, including cancer, mental health and substance use disorders, musculoskeletal conditions, cardiovascular diseases, and neurological conditions, together accounted for around 64% of the total disease burden. These predominantly long-term illnesses often necessitate sustained IV therapy for hydration, nutrition, and medication administration, significantly increasing demand for IV solutions. This growing clinical need is expected to support steady market expansion.
The market is experiencing several key trends, including the expansion of onshore IV fluid manufacturing and the advancement of AI-powered IV drug verification to enhance safety.
Onshore IV Fluid Manufacturing Expansions to Boost Market Growth in Australia
The strategic shift toward strengthening onshore manufacturing capabilities to secure critical medical supplies is a key trend driving the market. In March 2025, the Australian Government announced a USD 20 million investment to expand local production of intravenous fluids, in collaboration with Baxter Healthcare. This initiative follows previous global supply disruptions and aims to produce 80 million units annually by 2027. Such sovereign capability enhancements are poised to reduce import reliance and significantly enhance long-term market growth.
AI-Powered IV Drug Verification Advancing Safety to Boost Australia Intravenous Solution Market Value
The market is witnessing a growing trend toward the adoption of advanced AI-driven verification technologies to improve safety in intravenous drug administration. For instance, in July 2025, Veriphi introduced its laser based IV drug verification system at St Vincent’s Hospital Melbourne, marking a global first in sterile oncology compounding. This innovation enables real-time, non-invasive drug validation, reducing errors and easing clinician workload. Such advancements are reinforcing trust in IV therapies, thereby accelerating the growth of the intravenous solution market across Australia.
Total Parenteral Nutrition to Lead the Market by Type
The market in Australia comprises essential types, including partial parenteral nutrition and total parenteral nutrition (TPN), each tailored to meet different clinical nutritional needs. Among these, total parenteral nutrition is poised to take the lead owing to its critical role in delivering complete nutritional support to patients unable to utilize their gastrointestinal tract. This segment’s anticipated growth is propelled by the rising incidence of chronic diseases and an increasing number of hospitalizations requiring advanced intravenous nutritional therapies, establishing TPN as a cornerstone of patient care in Australia’s evolving healthcare landscape.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Ajinomoto Health & Nutrition supplies high-purity amino acids and medical-nutrition ingredients used in parenteral formulations and pharmaceutical manufacture. In the Australia IV space the company supports parenteral nutrition and IV therapy indirectly, by supplying compendial amino acids, premix components and technical expertise that formulators, hospitals and contract manufacturers use to produce ready-to-use PN and specialty IV products. Their focus is on ingredient quality, regulatory compliance and collaboration with local manufacturers and clinical nutrition stakeholders.
B. Braun is active in Australia with a broad infusion-therapy portfolio that includes IV fluids, infusion pumps, IV sets and clinical services. The company works with Australian hospitals and clinicians to deliver integrated infusion solutions, training and safety programs, and supplies replacement and specialty IV fluids for inpatient and outpatient care. Their presence emphasizes end-to-end infusion therapy management — from devices and consumables to clinician education and support.
ICU Medical engages the Australian market through infusion therapy consumables, IV sets, needle-free connectors and flexible IV solution containers designed for safe medication delivery and infection control. In Australia the company markets IV administration systems and support services used across critical care, NICU/PICU and general wards, positioning its products to improve bedside safety, additive workflows and compatibility with regional hospital pharmacy processes.
Baxter is a long-standing supplier and onshore manufacturer of IV fluids and parenteral nutrition solutions in Australia, providing premix IV solutions, clinical nutrition products, compounding technology and pharmacy workflow support. The company partners with health services and governments on supply continuity and local production initiatives, and supplies IV fluids, lipids and PN products used across hospitals and home-care settings while supporting clinician education and supply-chain resilience.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Fresenius Kabi AG, Pfizer Inc., Otsuka Pharmaceutical Co., Ltd., and Vifor Pharma Management Ltd.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Nutrients
Market Breakup by Bag Type
Market Breakup by Application
Market Breakup by End User
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Nutrients |
|
| Breakup by Bag Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share